Borgia, P.; Piccolo, G.; Santangelo, A.; Chelleri, C.; Viglizzo, G.; Occella, C.; Minetti, C.; Striano, P.; Diana, M.C.
Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management. J. Clin. Med. 2024, 13, 1792.
https://doi.org/10.3390/jcm13061792
AMA Style
Borgia P, Piccolo G, Santangelo A, Chelleri C, Viglizzo G, Occella C, Minetti C, Striano P, Diana MC.
Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management. Journal of Clinical Medicine. 2024; 13(6):1792.
https://doi.org/10.3390/jcm13061792
Chicago/Turabian Style
Borgia, Paola, Gianluca Piccolo, Andrea Santangelo, Cristina Chelleri, Gianmaria Viglizzo, Corrado Occella, Carlo Minetti, Pasquale Striano, and Maria Cristina Diana.
2024. "Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management" Journal of Clinical Medicine 13, no. 6: 1792.
https://doi.org/10.3390/jcm13061792
APA Style
Borgia, P., Piccolo, G., Santangelo, A., Chelleri, C., Viglizzo, G., Occella, C., Minetti, C., Striano, P., & Diana, M. C.
(2024). Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management. Journal of Clinical Medicine, 13(6), 1792.
https://doi.org/10.3390/jcm13061792